du pont (e.i.) de nemours (DD:New York)
Diane H. Gulyas
Former President of Performance Polymers Segment, E. I. du Pont de Nemours and Company
|Age||Total Calculated Compensation||This person is connected to 26 board members in 3 different organizations across 6 different industries.|
See Board Relationships
Ms. Diane H. Gulyas served as the President of Performance Polymers Segment at E. I. du Pont de Nemours and Company from October 2009 to March 1, 2014. Ms. Gulyas served as Group Vice President of DuPont Performance Materials at E. I. du Pont de Nemours and Company since April 2006. She served as a Group Vice President of DuPont Electronics & Communication Technologies from February 2002 to April 2004. Ms. Gulyas served as the Chief Marketing and Sales Officer of E. ...
1007 Market StreetPhone: 302-774-1000
Wilmington, Delaware 19898
Board Members Memberships*
Former Director and Member of Audit Committee
Director and Member of Audit Committee
Former Director and Member of Finance Committee
Independent Director, Member of Audit Committee and Member of Compensation & Human Resources Committee
Director, Member of Compensation Committee, Member of Nominating & Governance Committee, Member of Audit Committee and Member of Corporate Responsibility Committee
University of Notre Dame
Unknown/Other Education 1994
University of Pennsylvania - The Wharton School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Rajiv Kanishka Liyanaarchchie De Silva||Chief Executive Officer, President and Director|
Endo International plc
|Yves L'epine||Chief Executive Officer, Director and Member of Strategy & Innovation Committee|
|Olivier Legrain||Chief Executive Officer, President, Director and Member of Nomination Committee|
Ion Beam Applications, S.A.
|Arthur P. Bedrosian J.D.||Chief Executive Officer, Director and Chairman of Strategic Planning Committee|
Lannett Company, Inc.
|A. J. Kazimi MBA||Founder, Chairman, Chief Executive Officer and President|
Cumberland Pharmaceuticals, Inc.
|$620.0K||Compensation as of Fiscal Year 2013.|